Tissue plasminogen activator in murine exocrine pancreas cancer - Selective expression in ductal tumors and contribution to cancer progression

被引:29
作者
Aguilar, S
Corominas, JM
Malats, N
Pereira, JA
Dufresne, M
Real, FX
Navarro, P
机构
[1] Inst Municipal Invest Med, Unitat Biol Cellular & Mol, E-08003 Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Patol, Barcelona, Spain
[3] Univ Autonoma Barcelona, Hosp del Mar, Barcelona, Spain
[4] Unitat Rec Resp & Ambiental, Barcelona, Spain
[5] Inst Municipal Invest Med, E-08003 Barcelona, Spain
[6] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona, Spain
[7] Univ Pompeu Fabra, Fac Ciencias Salut & Vida, Barcelona, Spain
[8] Inst Louis Bugnard, INSERM, U531, Toulouse, France
关键词
D O I
10.1016/S0002-9440(10)63374-3
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Tissue plasminogen activator (tPA) is absent from normal human pancreas and is expressed in 95% of human pancreatic adenocarcinomas. We have analyzed the expression of components of the tPA system in murine pancreatic tumors and the role of tPA in neoplastic progression. Transgenic mice expressing T antigen and c-myc under the control of the elastase promoter (Ela1-TAg and Ela1-myc, respectively) were used. tPA was undetectable in normal pancreas, acinar dysplasia, ductal complexes, and in all acinar tumors. By contrast, it was consistently detected in Ela1-myc tumors showing ductal differentiation. Crossing transgenic Ela1-myc with tPA-/- mice had no effect on the proportion of ductal tumors, indicating that tPA is not involved in the acinar-to-ductal transition. Ela1-myc:tPA-/- mice showed an increased survival in comparison to control mice. All ductal tumors, and none of the acinar tumors, overexpressed the tPA receptor annexin A2, suggesting its participation in the effects mediated by tPA. Our findings indicate that murine and human pancreatic ductal tumors share molecular alterations in the tPA system that may play a role in tumor progression.
引用
收藏
页码:1129 / 1139
页数:11
相关论文
共 63 条
[1]
Adell T, 2000, CELL GROWTH DIFFER, V11, P137
[2]
*AM GASTR ASS, 1999, GASTROENTEROLOGY, V117, P1463
[3]
[Anonymous], 2001, CANC PRICIPLES PRACT
[4]
Cancer as a complex genetic trait: Tumor susceptibility in humans and mouse models [J].
Balmain, A .
CELL, 2002, 108 (02) :145-152
[5]
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model [J].
Bardeesy, N ;
Sharpless, NE ;
DePinho, RA ;
Merlino, G .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (03) :201-218
[6]
Breslow N., 1984, CANCER CLIN TRIALS, P381
[7]
PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[8]
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444
[9]
CESARMAN GM, 1994, J BIOL CHEM, V269, P21198
[10]
Expression of CCK2 receptors in the murine pancreas: Proliferation, transdifferentiation of acinar cells, and neoplasia [J].
Clerc, P ;
Leung-Theung-Long, S ;
Wang, TC ;
Dockray, GJ ;
Bouisson, M ;
Delisle, MB ;
Vaysse, N ;
Pradayrol, L ;
Fourmy, D ;
Dufresne, M .
GASTROENTEROLOGY, 2002, 122 (02) :428-437